TARSTarsus Pharmaceuticals, Inc.
- Market cap
- $3.19B
- as of 2026-10-23
- Latest close
- $68.20
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-06
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Pyott David E I | Sep 15 | Sep 17 | M | 201 | not reported | not reported | 9,575 | No | Form 4 |
| Pyott David E I | Sep 15 | Sep 17 | M · derivative | 201 | $0.00 | $0 | 605 | No | Form 4 |
| Yarno Wendy L | Sep 15 | Sep 17 | M | 302 | not reported | not reported | 16,956 | No | Form 4 |
| Yarno Wendy L | Sep 15 | Sep 17 | M · derivative | 302 | $0.00 | $0 | 907 | No | Form 4 |
| Link William J Phd | Sep 15 | Sep 17 | M | 201 | not reported | not reported | 106,987 | Yes | Form 4 |
| Link William J Phd | Sep 15 | Sep 17 | S | 11,675 | $78.33 | Sale −$914,503 | 95,312 | Yes | Form 4 |
| Link William J Phd | Sep 15 | Sep 17 | S | 759 | $79.00 | Sale −$59,961 | 94,553 | Yes | Form 4 |
| Link William J Phd | Sep 15 | Sep 17 | S | 66 | $80.01 | Sale −$5,281 | 94,487 | Yes | Form 4 |
| Link William J Phd | Sep 15 | Sep 17 | M · derivative | 201 | $0.00 | $0 | 605 | Yes | Form 4 |
| Neervannan SeshadriChief Operating Officer | Sep 4 | Sep 9 | S | 4,564 | $85.00 | Sale −$387,940 | 78,532 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Sep 4 | Sep 9 | S | 7,100 | $90.27 | Sale −$640,917 | 830,891 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Sep 4 | Sep 9 | S | 2,900 | $91.27 | Sale −$264,683 | 827,991 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 4 | Sep 9 | S | 5,387 | $85.00 | Sale −$457,895 | 7,933 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 4 | Sep 9 | S | 5,386 | $90.00 | Sale −$484,740 | 2,547 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 4 | Sep 9 | S | 1,590 | $85.00 | Sale −$135,150 | 3,180 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 4 | Sep 9 | S | 1,590 | $90.00 | Sale −$143,100 | 1,590 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Sep 2 | Sep 3 | S | 10,000 | $80.06 | Sale −$800,600 | 837,991 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 2 | Sep 3 | S | 5,387 | $80.00 | Sale −$430,960 | 13,320 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 2 | Sep 3 | S | 1,590 | $80.00 | Sale −$127,200 | 4,770 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Sep 1 | Sep 3 | S | 4,601 | $73.86 | Sale −$339,830 | 18,707 | Yes | Form 4 |
| Pyott David E I | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Pyott David E I | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Pyott David E I | Jun 25 | Jun 29 | A · derivative | 806 | $0.00 | $0 | 806 | No | Form 4 |
| Yarno Wendy L | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Yarno Wendy L | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Yarno Wendy L | Jun 25 | Jun 29 | A · derivative | 1,209 | $0.00 | $0 | 1,209 | No | Form 4 |
| Link William J Phd | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Link William J Phd | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Link William J Phd | Jun 25 | Jun 29 | A · derivative | 806 | $0.00 | $0 | 806 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Morrison Scott W | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Morrison Scott W | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Goldberg Andrew D. | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Goldberg Andrew D. | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Goodrich Katherine | Jun 25 | Jun 29 | A · derivative | 3,837 | $64.34 | $246,873 | 3,837 | No | Form 4 |
| Goodrich Katherine | Jun 25 | Jun 29 | A · derivative | 2,417 | $0.00 | $0 | 2,417 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Jun 17 | Jun 22 | S | 4,582 | $61.24 | Sale −$280,602 | 853,409 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Jun 17 | Jun 22 | S | 5,418 | $61.81 | Sale −$334,887 | 847,991 | Yes | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 16 | Jun 17 | S | 14,396 | $60.95 | Sale −$877,436 | 56,801 | No | Form 4 |
| Link William J Phd | Jun 15 | Jun 17 | S | 10,572 | $61.97 | Sale −$655,147 | 108,714 | Yes | Form 4 |
| Link William J Phd | Jun 15 | Jun 17 | S | 1,928 | $62.94 | Sale −$121,348 | 106,786 | Yes | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 15 | Jun 17 | M | 27,881 | not reported | not reported | 71,197 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 15 | Jun 17 | M · derivative | 27,881 | $0.00 | $0 | 27,882 | No | Form 4 |
| Goodrich Katherine | Jun 15 | Jun 17 | S | 2,954 | $62.08 | Sale −$183,384 | 2,233 | Yes | Form 4 |
| Yarno Wendy L | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 16,654 | No | Form 4 |
| Yarno Wendy L | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Link William J Phd | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 119,286 | No | Form 4 |
| Link William J Phd | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Chaudhuri Bhaskar | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 11,654 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Morrison Scott W | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 7,638 | No | Form 4 |
| Morrison Scott W | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Goldberg Andrew D. | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 19,654 | No | Form 4 |
| Goldberg Andrew D. | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Goodrich Katherine | Jun 12 | Jun 16 | M | 2,954 | not reported | not reported | 5,187 | No | Form 4 |
| Goodrich Katherine | Jun 12 | Jun 16 | M · derivative | 2,954 | $0.00 | $0 | not reported | No | Form 4 |
| Pyott David E I | Apr 24 | Apr 28 | M | 1,383 | not reported | not reported | 1,383 | No | Form 4 |
| Pyott David E I | Apr 24 | Apr 28 | M · derivative | 1,383 | $0.00 | $0 | not reported | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 20 | Mar 24 | S | 2,989 | $66.75 | Sale −$199,516 | 82,791 | Yes | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 19 | Mar 19 | S | 2,186 | $67.00 | Sale −$146,462 | 43,316 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 19 | Mar 19 | S | 4,440 | $67.00 | Sale −$297,480 | 61,480 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 19 | Mar 19 | S | 4,589 | $67.00 | Sale −$307,463 | 85,780 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 19 | Mar 19 | S | 11,964 | $67.00 | Sale −$801,588 | 33,421 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 19 | Mar 19 | S | 4,174 | $67.00 | Sale −$279,658 | 35,028 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 19 | Mar 19 | S | 4,231 | $67.00 | Sale −$283,477 | 63,959 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 19 | Mar 19 | S | 390 | $67.00 | Sale −$26,130 | 23,308 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 18 | Mar 19 | S | 2,133 | $68.71 | Sale −$146,558 | 45,502 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 18 | Mar 19 | S | 4,330 | $68.71 | Sale −$297,514 | 65,920 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 18 | Mar 19 | S | 3,610 | $68.71 | Sale −$248,043 | 90,369 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 18 | Mar 19 | S | 11,667 | $68.71 | Sale −$801,640 | 45,385 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 18 | Mar 19 | S | 4,071 | $68.71 | Sale −$279,718 | 39,202 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 18 | Mar 19 | S | 4,125 | $68.71 | Sale −$283,429 | 68,190 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 18 | Mar 19 | S | 379 | $68.71 | Sale −$26,041 | 23,698 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 17 | Mar 19 | S | 2,111 | $69.42 | Sale −$146,546 | 47,635 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 17 | Mar 19 | S | 4,286 | $69.42 | Sale −$297,534 | 70,250 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 17 | Mar 19 | S | 3,125 | $69.42 | Sale −$216,938 | 93,979 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 17 | Mar 19 | S | 10,972 | $69.42 | Sale −$761,676 | 57,052 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 17 | Mar 19 | S | 4,029 | $69.42 | Sale −$279,693 | 43,273 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 17 | Mar 19 | S | 4,084 | $69.42 | Sale −$283,511 | 72,315 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 17 | Mar 19 | S | 375 | $69.42 | Sale −$26,033 | 24,077 | No | Form 4 |
| Link William J Phd | Mar 16 | Mar 18 | S | 3,629 | $68.09 | Sale −$247,099 | 125,203 | Yes | Form 4 |
| Link William J Phd | Mar 16 | Mar 18 | S | 8,378 | $69.03 | Sale −$578,333 | 116,825 | Yes | Form 4 |
| Link William J Phd | Mar 16 | Mar 18 | S | 493 | $69.75 | Sale −$34,387 | 116,332 | Yes | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 15 | Mar 17 | M | 13,042 | not reported | not reported | 49,746 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 15 | Mar 17 | M · derivative | 8,020 | $0.00 | $0 | 16,040 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 15 | Mar 17 | M · derivative | 5,022 | $0.00 | $0 | 15,067 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15 | Mar 17 | M | 26,482 | not reported | not reported | 74,536 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15 | Mar 17 | M · derivative | 4,790 | $0.00 | $0 | not reported | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15 | Mar 17 | M · derivative | 8,148 | $0.00 | $0 | 8,148 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15 | Mar 17 | M · derivative | 8,020 | $0.00 | $0 | 16,040 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15 | Mar 17 | M · derivative | 5,524 | $0.00 | $0 | 16,574 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15 | Mar 17 | M | 26,287 | not reported | not reported | 97,104 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15 | Mar 17 | M · derivative | 5,097 | $0.00 | $0 | not reported | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15 | Mar 17 | M · derivative | 8,148 | $0.00 | $0 | 8,148 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15 | Mar 17 | M · derivative | 8,020 | $0.00 | $0 | 16,040 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15 | Mar 17 | M · derivative | 5,022 | $0.00 | $0 | 15,067 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15 | Mar 17 | M | 66,274 | not reported | not reported | 68,024 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15 | Mar 17 | M · derivative | 11,300 | $0.00 | $0 | not reported | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15 | Mar 17 | M · derivative | 16,975 | $0.00 | $0 | 16,975 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15 | Mar 17 | M · derivative | 23,121 | $0.00 | $0 | 46,243 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15 | Mar 17 | M · derivative | 14,878 | $0.00 | $0 | 44,634 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15 | Mar 17 | M | 23,909 | not reported | not reported | 47,302 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15 | Mar 17 | M · derivative | 4,463 | $0.00 | $0 | not reported | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15 | Mar 17 | M · derivative | 7,248 | $0.00 | $0 | 7,249 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15 | Mar 17 | M · derivative | 7,176 | $0.00 | $0 | 14,351 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15 | Mar 17 | M · derivative | 5,022 | $0.00 | $0 | 15,067 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15 | Mar 17 | M | 24,236 | not reported | not reported | 76,399 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15 | Mar 17 | M · derivative | 4,790 | $0.00 | $0 | not reported | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15 | Mar 17 | M · derivative | 7,248 | $0.00 | $0 | 7,249 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15 | Mar 17 | M · derivative | 7,176 | $0.00 | $0 | 14,351 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15 | Mar 17 | M · derivative | 5,022 | $0.00 | $0 | 15,067 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 15 | Mar 17 | M | 2,511 | not reported | not reported | 24,452 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 15 | Mar 17 | M · derivative | 2,511 | $0.00 | $0 | 7,534 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 5 | Mar 9 | A · derivative | 30,724 | $74.90 | $2,301,228 | 30,724 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 5 | Mar 9 | A · derivative | 19,306 | $0.00 | $0 | 19,306 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 5 | Mar 9 | A · derivative | 30,724 | $74.90 | $2,301,228 | 30,724 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 5 | Mar 9 | A · derivative | 19,306 | $0.00 | $0 | 19,306 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 5 | Mar 9 | A · derivative | 27,310 | $74.90 | $2,045,519 | 27,310 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 5 | Mar 9 | A · derivative | 17,161 | $0.00 | $0 | 17,161 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 5 | Mar 9 | A · derivative | 96,723 | $74.90 | $7,244,553 | 96,723 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 5 | Mar 9 | A · derivative | 60,776 | $0.00 | $0 | 60,776 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 5 | Mar 9 | A · derivative | 27,310 | $74.90 | $2,045,519 | 27,310 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 5 | Mar 9 | A · derivative | 17,161 | $0.00 | $0 | 17,161 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 5 | Mar 9 | A · derivative | 27,310 | $74.90 | $2,045,519 | 27,310 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 5 | Mar 9 | A · derivative | 17,161 | $0.00 | $0 | 17,161 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 5 | Mar 9 | A · derivative | 27,310 | $74.90 | $2,045,519 | 27,310 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 5 | Mar 9 | A · derivative | 17,161 | $0.00 | $0 | 17,161 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 4 | Mar 5 | S | 8,366 | $76.67 | Sale −$641,421 | 70,817 | Yes | Form 4 |
| Pyott David E I | Feb 18 | Feb 20 | A · derivative | 5,893 | $63.27 | $372,850 | 5,893 | No | Form 4 |
| Pyott David E I | Feb 18 | Feb 20 | A · derivative | 3,729 | $0.00 | $0 | 3,729 | No | Form 4 |
| Goodrich Katherine | Dec 15, 2025 | Jan 14 | M | 2,233 | not reported | not reported | 2,233 | No | Form 4 |
| Goodrich Katherine | Dec 15, 2025 | Jan 14 | M · derivative | 2,233 | $0.00 | $0 | 4,467 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Jan 2 | Jan 6 | S | 5,715 | $80.09 | Sale −$457,714 | 33,243 | Yes | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Jan 2 | Jan 6 | S | 8,122 | $80.71 | Sale −$655,527 | 25,121 | Yes | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Jan 2 | Jan 6 | S | 835 | $81.90 | Sale −$68,387 | 24,286 | Yes | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Jan 2 | Jan 6 | S | 893 | $82.93 | Sale −$74,056 | 23,393 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 24, 2025 | Dec 30, 2025 | S | 5,443 | $82.41 | Sale −$448,558 | 858,548 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 24, 2025 | Dec 30, 2025 | S | 557 | $83.54 | Sale −$46,532 | 857,991 | Yes | Form 4 |
| Neervannan SeshadriChief Operating Officer | Dec 16, 2025 | Dec 18, 2025 | G | 950 | $0.00 | $0 | 79,183 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Dec 16, 2025 | Dec 18, 2025 | G | 475 | $0.00 | $0 | 475 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Dec 16, 2025 | Dec 18, 2025 | S | 7,397 | $80.10 | Sale −$592,500 | 38,958 | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Dec 16, 2025 | Dec 17, 2025 | S | 2,078 | $79.50 | Sale −$165,201 | 21,941 | No | Form 4 |
| Link William J Phd | Dec 15, 2025 | Dec 17, 2025 | S | 5,046 | $80.80 | Sale −$407,717 | 136,286 | Yes | Form 4 |
| Link William J Phd | Dec 15, 2025 | Dec 17, 2025 | S | 6,306 | $81.75 | Sale −$515,516 | 129,980 | Yes | Form 4 |
| Link William J Phd | Dec 15, 2025 | Dec 17, 2025 | S | 1,148 | $82.39 | Sale −$94,584 | 128,832 | Yes | Form 4 |
| Link William J Phd | Dec 15, 2025 | Dec 17, 2025 | S | 5,680 | $80.71 | Sale −$458,433 | 4,766 | Yes | Form 4 |
| Link William J Phd | Dec 15, 2025 | Dec 17, 2025 | S | 4,766 | $81.50 | Sale −$388,429 | not reported | Yes | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Dec 15, 2025 | Dec 17, 2025 | M | 6,819 | not reported | not reported | 24,019 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Dec 15, 2025 | Dec 17, 2025 | M · derivative | 6,819 | $0.00 | $0 | 20,459 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 4, 2025 | Dec 8, 2025 | G | 51,885 | $0.00 | $0 | 1,750 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Sep 24, 2025 | Sep 26, 2025 | S | 6,000 | $55.37 | Sale −$332,220 | 812,106 | Yes | Form 4 |
| Link William J Phd | Sep 16, 2025 | Sep 18, 2025 | G | 2,000 | $0.00 | $0 | 141,332 | No | Form 4 |
| Morrison Scott W | Sep 15, 2025 | Sep 16, 2025 | M | 1,334 | not reported | not reported | 4,684 | No | Form 4 |
| Morrison Scott W | Sep 15, 2025 | Sep 16, 2025 | M · derivative | 1,334 | $0.00 | $0 | not reported | No | Form 4 |
| Link William J Phd | Sep 8, 2025 | Sep 10, 2025 | S | 27,116 | $57.00 | Sale −$1,545,612 | 143,332 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Aug 11, 2025 | Aug 13, 2025 | S | 6,000 | $50.00 | Sale −$300,000 | 818,106 | Yes | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 17, 2025 | Jun 18, 2025 | S | 13,608 | $40.42 | Sale −$550,035 | 36,704 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 16, 2025 | Jun 18, 2025 | M | 27,881 | not reported | not reported | 50,312 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 16, 2025 | Jun 18, 2025 | M · derivative | 27,881 | $0.00 | $0 | 55,763 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Jun 16, 2025 | Jun 17, 2025 | S | 1,006 | $41.08 | Sale −$41,326 | 7,694 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Jun 13, 2025 | Jun 17, 2025 | M | 3,350 | not reported | not reported | 8,700 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Jun 13, 2025 | Jun 17, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Link William J Phd | Jun 13, 2025 | Jun 16, 2025 | M | 3,350 | not reported | not reported | 170,448 | No | Form 4 |
| Link William J Phd | Jun 13, 2025 | Jun 16, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Morrison Scott W | Jun 13, 2025 | Jun 16, 2025 | M | 3,350 | not reported | not reported | 3,350 | No | Form 4 |
| Morrison Scott W | Jun 13, 2025 | Jun 16, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Yarno Wendy L | Jun 13, 2025 | Jun 16, 2025 | M | 3,350 | not reported | not reported | 13,700 | No | Form 4 |
| Yarno Wendy L | Jun 13, 2025 | Jun 16, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Goldberg Andrew D. | Jun 13, 2025 | Jun 16, 2025 | M | 3,350 | not reported | not reported | 16,700 | No | Form 4 |
| Goldberg Andrew D. | Jun 13, 2025 | Jun 16, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Chaudhuri Bhaskar | Jun 13, 2025 | Jun 16, 2025 | M | 3,350 | not reported | not reported | 8,700 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 13, 2025 | Jun 16, 2025 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Link William J Phd | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Link William J Phd | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Morrison Scott W | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Morrison Scott W | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Yarno Wendy L | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Yarno Wendy L | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Goldberg Andrew D. | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Goldberg Andrew D. | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Goodrich Katherine | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Goodrich Katherine | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 4,540 | $40.95 | $185,913 | 4,540 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 12, 2025 | Jun 16, 2025 | A · derivative | 2,954 | $0.00 | $0 | 2,954 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Jun 9, 2025 | Jun 11, 2025 | S | 17,500 | $43.76 | Sale −$765,800 | 47,557 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 24, 2025 | Mar 26, 2025 | S | 6,000 | $50.00 | Sale −$300,000 | 824,106 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 20, 2025 | Mar 20, 2025 | S | 1,186 | $50.11 | Sale −$59,430 | 22,431 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 20, 2025 | Mar 20, 2025 | S | 8,534 | $50.11 | Sale −$427,639 | 53,635 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 20, 2025 | Mar 20, 2025 | S | 2,137 | $50.11 | Sale −$107,085 | 46,355 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 20, 2025 | Mar 20, 2025 | S | 3,084 | $50.11 | Sale −$154,539 | 51,712 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 20, 2025 | Mar 20, 2025 | S | 2,435 | $50.11 | Sale −$122,018 | 79,682 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 20, 2025 | Mar 20, 2025 | S | 3,365 | $50.11 | Sale −$168,620 | 65,057 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 19, 2025 | Mar 20, 2025 | S | 1,254 | $47.40 | Sale −$59,440 | 23,617 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 19, 2025 | Mar 20, 2025 | S | 8,551 | $47.40 | Sale −$405,317 | 62,169 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 19, 2025 | Mar 20, 2025 | S | 2,259 | $47.40 | Sale −$107,077 | 48,492 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 19, 2025 | Mar 20, 2025 | S | 3,261 | $47.40 | Sale −$154,571 | 54,796 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 19, 2025 | Mar 20, 2025 | S | 2,543 | $47.40 | Sale −$120,538 | 82,117 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 19, 2025 | Mar 20, 2025 | S | 3,557 | $47.40 | Sale −$168,602 | 68,422 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 18, 2025 | Mar 20, 2025 | S | 1,284 | $46.29 | Sale −$59,436 | 24,871 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 18, 2025 | Mar 20, 2025 | S | 7,131 | $46.29 | Sale −$330,094 | 70,720 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 18, 2025 | Mar 20, 2025 | S | 2,315 | $46.29 | Sale −$107,161 | 50,751 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 18, 2025 | Mar 20, 2025 | S | 3,341 | $46.29 | Sale −$154,655 | 58,057 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 18, 2025 | Mar 20, 2025 | S | 2,605 | $46.29 | Sale −$120,585 | 84,660 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 18, 2025 | Mar 20, 2025 | S | 3,643 | $46.29 | Sale −$168,634 | 71,979 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 17, 2025 | Mar 18, 2025 | M · derivative | 8,019 | $0.00 | $0 | 24,060 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2025 | Mar 18, 2025 | M | 20,957 | not reported | not reported | 75,622 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 4,790 | $0.00 | $0 | 4,790 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 8,148 | $0.00 | $0 | 16,296 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 8,019 | $0.00 | $0 | 24,060 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2025 | Mar 18, 2025 | M | 21,264 | not reported | not reported | 87,265 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 5,097 | $0.00 | $0 | 5,097 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 8,148 | $0.00 | $0 | 16,296 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 8,019 | $0.00 | $0 | 24,060 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2025 | Mar 18, 2025 | M | 19,213 | not reported | not reported | 61,398 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 4,790 | $0.00 | $0 | 4,790 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 7,248 | $0.00 | $0 | 14,497 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 7,175 | $0.00 | $0 | 21,527 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2025 | Mar 18, 2025 | M | 18,885 | not reported | not reported | 53,066 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 4,462 | $0.00 | $0 | 4,463 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 7,248 | $0.00 | $0 | 14,497 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 7,175 | $0.00 | $0 | 21,527 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2025 | Mar 18, 2025 | M | 51,395 | not reported | not reported | 77,851 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 11,299 | $0.00 | $0 | 11,300 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 16,975 | $0.00 | $0 | 33,950 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2025 | Mar 18, 2025 | M · derivative | 23,121 | $0.00 | $0 | 69,364 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 15, 2025 | Mar 18, 2025 | M | 8,019 | not reported | not reported | 26,155 | No | Form 4 |
| Goldberg Andrew D. | Mar 7, 2025 | Mar 11, 2025 | M | 7,000 | $12.89 | $90,230 | 13,350 | No | Form 4 |
| Goldberg Andrew D. | Mar 7, 2025 | Mar 11, 2025 | M · derivative | 7,000 | $12.89 | $90,230 | not reported | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 15,314 | $44.54 | $682,086 | 15,314 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 10,045 | $0.00 | $0 | 10,045 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 90,736 | $44.54 | $4,041,381 | 90,736 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 59,512 | $0.00 | $0 | 59,512 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 30,628 | $44.54 | $1,364,171 | 30,628 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 20,089 | $0.00 | $0 | 20,089 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 30,628 | $44.54 | $1,364,171 | 30,628 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 20,089 | $0.00 | $0 | 20,089 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 33,691 | $44.54 | $1,500,597 | 33,691 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 22,098 | $0.00 | $0 | 22,098 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 30,628 | $44.54 | $1,364,171 | 30,628 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 20,089 | $0.00 | $0 | 20,089 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 30,628 | $44.54 | $1,364,171 | 30,628 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 5, 2025 | Mar 7, 2025 | A · derivative | 20,089 | $0.00 | $0 | 20,089 | No | Form 4 |
| Goodrich Katherine | Nov 13, 2024 | Nov 15, 2024 | A · derivative | 10,000 | $46.51 | $465,100 | 10,000 | No | Form 4 |
| Goodrich Katherine | Nov 13, 2024 | Nov 15, 2024 | A · derivative | 6,700 | $0.00 | $0 | 6,700 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Nov 4, 2024 | Nov 6, 2024 | A · derivative | 41,074 | $46.21 | $1,898,030 | 41,074 | No | Form 4 |
| Lin Elizabeth YeuChief Medical Officer | Nov 4, 2024 | Nov 6, 2024 | A · derivative | 27,278 | $0.00 | $0 | 27,278 | No | Form 4 |
| Morrison Scott W | Sep 30, 2024 | Oct 2, 2024 | G | 6,016 | $0.00 | $0 | not reported | No | Form 4 |
| Morrison Scott W | Sep 15, 2024 | Sep 17, 2024 | M | 1,333 | not reported | not reported | 6,016 | No | Form 4 |
| Morrison Scott W | Sep 15, 2024 | Sep 17, 2024 | M · derivative | 1,333 | $0.00 | $0 | 1,334 | No | Form 4 |
| Link William J Phd | Aug 12, 2024 | Aug 14, 2024 | J | 74,892 | $0.00 | $0 | 35,000 | No | Form 4 |
| Link William J Phd | Aug 12, 2024 | Aug 14, 2024 | J | 10,446 | $0.00 | $0 | 10,446 | No | Form 4 |
| Link William J Phd | Aug 12, 2024 | Aug 14, 2024 | J | 27,116 | $0.00 | $0 | 167,098 | No | Form 4 |
| Link William J Phd | Aug 12, 2024 | Aug 14, 2024 | S | 29,979 | $26.01 | Sale −$779,754 | 5,021 | No | Form 4 |
| Link William J Phd | Aug 12, 2024 | Aug 14, 2024 | S | 5,021 | $26.53 | Sale −$133,207 | not reported | No | Form 4 |
| Yarno Wendy L | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 10,350 | No | Form 4 |
| Yarno Wendy L | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Chaudhuri Bhaskar | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 5,350 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Morrison Scott W | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 4,683 | No | Form 4 |
| Morrison Scott W | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Lin Elizabeth Yeu | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 5,350 | No | Form 4 |
| Lin Elizabeth Yeu | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Link William J Phd | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 139,982 | No | Form 4 |
| Link William J Phd | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Goldberg Andrew D. | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 6,350 | No | Form 4 |
| Goldberg Andrew D. | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Crane Rosemary A | Jun 24, 2024 | Jun 25, 2024 | M | 3,350 | not reported | not reported | 5,350 | No | Form 4 |
| Crane Rosemary A | Jun 24, 2024 | Jun 25, 2024 | M · derivative | 3,350 | $0.00 | $0 | not reported | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 18, 2024 | Jun 20, 2024 | S | 10,445 | $27.47 | Sale −$286,924 | 18,136 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 17, 2024 | Jun 20, 2024 | M | 27,881 | not reported | not reported | 28,581 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Jun 17, 2024 | Jun 20, 2024 | M · derivative | 27,881 | $0.00 | $0 | 83,644 | No | Form 4 |
| Link William J Phd | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Link William J Phd | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Morrison Scott W | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Morrison Scott W | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Lin Elizabeth Yeu | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Lin Elizabeth Yeu | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Yarno Wendy L | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Yarno Wendy L | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Crane Rosemary A | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Crane Rosemary A | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Chaudhuri Bhaskar | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Goldberg Andrew D. | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 5,000 | $33.14 | $165,700 | 5,000 | No | Form 4 |
| Goldberg Andrew D. | Jun 13, 2024 | Jun 14, 2024 | A · derivative | 3,350 | $0.00 | $0 | 3,350 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 18, 2024 | Mar 19, 2024 | S | 4,879 | $30.60 | Sale −$149,297 | 64,767 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 18, 2024 | Mar 19, 2024 | S | 4,314 | $30.60 | Sale −$132,008 | 34,181 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 18, 2024 | Mar 19, 2024 | S | 10,415 | $30.60 | Sale −$318,699 | 26,456 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 18, 2024 | Mar 19, 2024 | S | 4,436 | $30.60 | Sale −$135,742 | 40,951 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 18, 2024 | Mar 19, 2024 | S | 4,766 | $30.60 | Sale −$145,840 | 54,075 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2024 | Mar 19, 2024 | M | 13,245 | not reported | not reported | 69,646 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 5,097 | $0.00 | $0 | 10,194 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 8,148 | $0.00 | $0 | 24,444 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2024 | Mar 19, 2024 | M | 11,711 | not reported | not reported | 38,495 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 4,463 | $0.00 | $0 | 8,925 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 7,248 | $0.00 | $0 | 21,745 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2024 | Mar 19, 2024 | M | 28,274 | not reported | not reported | 36,871 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 11,299 | $0.00 | $0 | 22,599 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 16,975 | $0.00 | $0 | 50,925 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2024 | Mar 19, 2024 | M | 12,038 | not reported | not reported | 45,387 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 4,790 | $0.00 | $0 | 9,580 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 7,248 | $0.00 | $0 | 21,745 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2024 | Mar 19, 2024 | M | 12,938 | not reported | not reported | 58,841 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 4,790 | $0.00 | $0 | 9,580 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 15, 2024 | Mar 19, 2024 | M · derivative | 8,148 | $0.00 | $0 | 24,444 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 47,500 | $35.50 | $1,686,250 | 47,500 | No | Form 4 |
| Neervannan SeshadriChief Operating Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 32,079 | $0.00 | $0 | 32,079 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 47,500 | $35.50 | $1,686,250 | 47,500 | No | Form 4 |
| Farrow Jeffrey SSee Remarks | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 32,079 | $0.00 | $0 | 32,079 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 42,500 | $35.50 | $1,508,750 | 42,500 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 28,702 | $0.00 | $0 | 28,702 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 47,500 | $35.50 | $1,686,250 | 47,500 | No | Form 4 |
| Mottiwala AzizChief Commercial Officer | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 32,079 | $0.00 | $0 | 32,079 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 136,947 | $35.50 | $4,861,619 | 136,947 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 92,485 | $0.00 | $0 | 92,485 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 42,500 | $35.50 | $1,508,750 | 42,500 | No | Form 4 |
| Wahl BryanGeneral Counsel | Mar 7, 2024 | Mar 11, 2024 | A · derivative | 28,702 | $0.00 | $0 | 28,702 | No | Form 4 |
| Lin Elizabeth Yeu | Jan 25, 2024 | Jan 30, 2024 | A · derivative | 10,000 | $26.25 | $262,500 | 10,000 | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 27, 2023 | Dec 29, 2023 | S | 8,000 | $20.22 | Sale −$161,760 | 830,106 | Yes | Form 4 |
| Trevejo Jose M.CHIEF MEDICAL OFFICER | Dec 20, 2023 | Dec 22, 2023 | S | 2,252 | $20.00 | Sale −$45,040 | 2,251 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 20, 2023 | Dec 22, 2023 | S | 9,443 | $19.96 | Sale −$188,482 | 868,663 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Dec 20, 2023 | Dec 22, 2023 | S | 30,557 | $20.36 | Sale −$622,141 | 838,106 | Yes | Form 4 |
| Goldberg Andrew D. | Dec 15, 2023 | Dec 19, 2023 | P | 1,000 | $18.96 | Purchase +$18,960 | 3,000 | No | Form 4 |
| Yarno Wendy L | Dec 2, 2023 | Dec 5, 2023 | M | 5,000 | not reported | not reported | 7,000 | No | Form 4 |
| Yarno Wendy L | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 5,000 | $0.00 | $0 | not reported | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Nov 30, 2023 | Dec 1, 2023 | S | 8,355 | $16.31 | Sale −$136,270 | 26,784 | No | Form 4 |
| Wahl BryanGeneral Counsel | Nov 30, 2023 | Dec 1, 2023 | S | 8,356 | $16.31 | Sale −$136,286 | 31,966 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Nov 29, 2023 | Dec 1, 2023 | M | 23,920 | $0.00 | $0 | 35,139 | No | Form 4 |
| Whitfield Dianne C.Chief Human Resources Officer | Nov 29, 2023 | Dec 1, 2023 | M · derivative | 23,920 | $0.00 | $0 | not reported | No | Form 4 |
| Wahl BryanGeneral Counsel | Nov 29, 2023 | Dec 1, 2023 | M | 23,920 | $0.00 | $0 | 40,322 | No | Form 4 |
| Wahl BryanGeneral Counsel | Nov 29, 2023 | Dec 1, 2023 | M · derivative | 23,920 | $0.00 | $0 | not reported | No | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Nov 15, 2023 | Nov 17, 2023 | S | 2,896 | $18.01 | Sale −$52,157 | 883,210 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Nov 15, 2023 | Nov 17, 2023 | S | 4,904 | $18.54 | Sale −$90,920 | 878,306 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Nov 15, 2023 | Nov 17, 2023 | S | 200 | $19.28 | Sale −$3,856 | 878,106 | Yes | Form 4 |
| Azamian Bobak R.President/CEO and Board Chair | Oct 18, 2023 | Oct 20, 2023 | S | 8,000 | $13.24 | Sale −$105,920 | 886,106 | Yes | Form 4 |
| Trevejo Jose M.CHIEF MEDICAL OFFICER | Oct 5, 2023 | Oct 6, 2023 | S | 1,604 | $18.00 | Sale −$28,872 | 4,503 | Yes | Form 4 |